Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stericat Gutstrings is a prominent Indian medical device company specializing in the manufacture and distribution of high-quality surgical sutures and wound closure solutions. Founded in 1985 and headquartered in Gurugram, India, the company offers a comprehensive range of absorbable and non-absorbable sutures, including catgut, silk, and synthetic polymer-based products. In 2015, Stericat Gutstrings was acquired by the French surgical group Peters Surgical for approximately $12 million, facilitating its integration into a global manufacturing and supply chain. The company operates a state-of-the-art facility in IMT-Manesar that is certified under ISO 13485, CE marking, and WHO GMP standards. Its products serve a diverse range of surgical specialties, including cardiovascular, orthopedic, and general surgery, across both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stericat Gutstrings.